Circulating Tumor Cells (CTCs) Market

The global  Circulating Tumor Cells (CTCs) market  size was USD 9.7 Billion in 2022 and is expected to register a revenue CAGR of 11.5% over the forecast period, according to the latest report by Reports and Data. The World Health Organization has stated that cancer is the second most common cause of death globally, and its incidence is increasing worldwide. As a result, there is a growing need for effective diagnostic and treatment options. Detecting circulating tumor cells (CTCs) is of great interest to patients and medical experts alike, as it offers a non-invasive approach to detecting and monitoring cancer. The liquid biopsy field's revenue growth is being propelled by the progress made in cancer detection methods. This involves analyzing biological fluids, such as blood, to identify specific cancer biomarkers. The utilization of advanced high-throughput screening technology has resulted in the identification of new biomarkers that can aid in the early detection of ca...